total-news-1024x279-1__1_-removebg-preview.png

SELECT LANGUAGE BELOW

Biotech CEO predicts ‘revolutionary’ move toward curing cancer is on the horizon thanks to AI

Sellas Life Sciences CEO Angelos Stergiou says his company is already on the cusp of a final leukemia vaccine, but thanks to artificial intelligence, another game changer – a personalized cancer vaccine is on the horizon Possibly.

“I think it's going to be a revolutionary decade in medicine and clinical research,” he said Thursday on “Fox & Friends.”

“Where AI comes in is where it allows us to do things quickly, and it's going to be more personalized. In other words, if you have a patient with cancer, you can use AI to sequence their genome. , and as a result, we can create a particular vaccine or treatment or say that this particular treatment will work for the patient.”

AI-designed drug for inflammatory bowel disease enters human clinical trials: 'critical need'

AI is expected to revolutionize cancer treatment within the next few years. (istock)

How long does the technique take? Stergiou predicts the first specialized vaccine could come within the next three to four years.

“It's really important to understand that if you put garbage into this algorithm, you'll get garbage out, so the medical community puts a lot of effort into making sure it fits that data set well. It's an evolutionary thing.”

Mark Beckman, an AI expert and author of “Future Days,” also joined “Fox & Friends” on Thursday.

AI can predict whether cancer treatments will work, experts say: 'Exciting time for medicine'

Speaking to the Couch on Curve host, he highlighted Google's new AI research system, Amie. It is designed to find rare diseases and act as a co-pilot for doctors.

“They've done some research and the ability to detect these rare diseases and conditions is now at a very high level, so doctors are using it as a tool to help with diagnosis.”

Click here to get the Fox News app

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp